Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.

"Declarations Conflict of interestDr. Brandman has received research support from Allergan, Conatus, and Grifols, and grant and research support from Gilead. She has served on an advisory board and consulted for Alnylam. Ethical approvalThis study was reviewed and approved by the UCSF Institutional Review Board. Conflict of interest Dr. Brandman has received research support from Allergan, Conatus, and Grifols, and grant and research support from Gilead. She has served on an advisory board and consulted for Alnylam."

"Funding This work was supported by (1) Gilead Sciences, Inc. “NASH Models of Care” program, Grant # IN-US-989-5737 (R. Fox, D. Brandman). (2) The San Francisco Cancer Initiative (SF CAN), a collaborative community effort initiated by the UCSF Helen Diller Family Comprehensive Cancer Center to reduce the cancer burden across San Francisco and beyond (www.sfcancer.org) (R. Fox). (3) National Research Service Award (NRSA) T32HP19025T-32 (J. Chu). The funders had no role in the analysis or interpretation of the data, the writing of the report, or the decision to submit the manuscript for publication."